Navigation Links
3SBio Inc. Announces Changes to Its Board of Directors
Date:8/9/2012

SHENYANG, China, Aug 9, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced changes to its board of directors.  

Mr. Lawrence Wizel has submitted his resignation from 3SBio's board of directors, effective September 1, 2012. Mr Wizel has served as an independent director since 2006. At the time of his resignation Mr Wizel was the chair of the audit committee and a member of the compensation committee and the investment committee. Mr. Wizel's decision to resign was due to health reasons and there is no disagreement between Mr. Wizel and the Company on any matter relating to the Company's operations, policies or practices.

Effective September 1, 2012, Mr. Tianruo (Robert) Pu will join 3SBio's board of directors as an independent director, with appointment to serve in the audit committee as the chair and in the compensation committee. Mr. Pu currently chairs the audit committee of UTStarcom Holdings Corp (NASDAQ: UTSI) and also serves on its other board committees. From September 2008 to June 2012, Mr. Pu was the chief financial officer of China Nuokang Bio-Pharmaceutical Inc. ("Nuokang Biopharma") (NASDAQ: NKBP) where he successfully led Nuokang Biopharma's IPO process and was responsible for its M&A and corporate growth strategy. Prior to joining Nuokang Biopharma, Mr. Pu was the chief financial officer of Global Data Solutions, a Chinese information technology services outsourcing company, which he joined in June 2006. From September 2000 to May 2006, he worked as a management consultant with Accenture, CSC Consulting Group and Mitchell Madison Consulting Group. He also worked as an auditor at Bernstein Brown CPAs from June 1994 to May 1997. Mr. Pu received an MBA degree fr
'/>"/>

SOURCE 3SBio Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
2. 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
3. 3SBio Inc. To Present at the DB Access Asia Conference 2012
4. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
5. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
6. Allscripts Announces Second Quarter 2012 Results
7. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
8. AHM Announces New SVP Product Delivery
9. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
10. InfuSystem Holdings, Inc. Reports $14.1 Million of Revenues for the Second Quarter of 2012; Announces Annualized Cost Savings in Excess of $1 million
11. Islet Sciences Announces Strategic Alliance with Spring Point Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... YORK , May 1, 2015  Shares of ... 70% of their value yesterday following the results of ... glaucoma therapy, Rhopressa.  Despite the trial failing to meet ... that positive results may come from future studies. ... brief company overview, current pipeline, financial review, analyst summary, ...
(Date:4/30/2015)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider ... today announced results for its first quarter ended March ... first quarter of 2015 was $116.2 million, up $14.5 ... and down $5.3 million or 4.4% from the fourth ... income as reported in accordance with U.S. generally accepted ...
(Date:4/30/2015)... April 30, 2015  Tandem Diabetes Care ® , Inc. ... of the t:slim ® and t:flex™ Insulin Pumps, today ... 2015. In comparing the first quarter of ... grew 53 percent to $12.3 million from $8.1 million ... from 1,723 pumps "Our investment in resources to ...
Breaking Medicine Technology:All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6
... The U.S. Food and Drug Administration today issued ... use needle-free clinical devices to administer influenza vaccinations. Based ... KR ) immediately discontinued use of such clinical devices ... The Kroger family of pharmacies and The ...
... Oct. 21, 2011 Robbins Umeda LLP, a ... into possible breaches of fiduciary duty and other violations ... KV Pharmaceutical Company (NYSE: KV-A, KV-B). ... investigation focuses on whether officials at KV Pharmaceuticals breached ...
Cached Medicine Technology:Robbins Umeda LLP Announces an Investigation of KV Pharmaceutical Company 2
(Date:5/2/2015)... 2015 Vancouver fencing company, QS Fencing, has ... advice to prospective clients related to their questions on railings ... railings around their decks and patios. While that seems like ... up once the person rolls up their sleeve to start ... railing in finding a gate that matches it. , Instead ...
(Date:5/2/2015)... Peachtree Audio ” was featured on NewsWatch as part ... and coolest technology products available to consumers. Scott Steinberg, ... the review and shared with viewers how this is ... important part of people’s lives – and as such, ... Peachtree Audio does just that with high-end audio equipment ...
(Date:5/2/2015)... With the success that Veatch Dental Consulting has had over ... and Alex Shields to the team. With Neida and Alex ... combined experience working with dentists to ensure their success. , ... years. She was certified as dental assistant from Texas ... and showing the importance of oral hygiene to patients, Neida ...
(Date:5/1/2015)... Royal River Natural Foods, a locally-owned ... a new study that found two natural nutrients, glucosamine ... physical function as well as standard drug treatment after ... knee. , The report is part of the May ... ,” which Royal River Natural Foods publishes for free ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Ernst & ... Dr. Joshua Rosenthal, Co-Founder & CSO, and Burak Sezen, ... for the EY Entrepreneur Of The Year® 2015 ... & Young is a global leader in assurance, ... to be one of the top audit companies in ...
Breaking Medicine News(10 mins):Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... highly complementary businesses - ... - $12-14 million of expected annual ... earnings per share in 2009, LISLE, IL, and PORT ... or the "Company") (NASDAQ: SXCI, TSX:,SXC) and National Medical Health ...
... ... http://www.cryocath.com , MONTREAL, Feb. 26 /PRNewswire-FirstCall/ - CryoCath(R) ... announced that Chief Financial Officer, L. Derek,Lindsay, will be leaving the ... take over the role of Chief Financial Officer at,CryoCath. Mr. Lindsay ...
... TSX: BMR, TORONTO, Feb. 26 ... company dedicated to the development and,commercialization ... Phase II data,on the Company,s Neuradiab ... newly,diagnosed glioblastoma multiforme (GBM) were published ...
... Minn., Feb. 26 Construction is,underway to expand ... size of the six-year-old location. When completed in ... procedure rooms, improved privacy for,inpatients waiting for procedures ... $2.1 million project also will provide expanded space ...
... Carriage Services, Inc.,(NYSE: CSV ) today announced plans to ... 2008 after the market closes. In,conjunction with the release, Carriage ... over the Internet, for Friday, March 7,2008 at 10:00 a.m. ... 2007 Earnings Conference Call, When: Friday, March 7, ...
... Billion With a 14% Rise in Core ... Broadband Business Merger Paying Off: Q4 Gross Margin of 33% & ... ... Market and TASE: SMLC), a,growth-oriented provider of communication services in Israel, today,reported its financial results ...
Cached Medicine News:Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 2Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 3Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 4Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 5Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 6Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 7Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 8Health News:CryoCath Appoints New Chief Financial Officer 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 3Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 4Health News:Expansion Will Double Size of The Heart Center at Regions Hospital 2Health News:Carriage Services Announces Fourth Quarter and Year-End Earnings Release and Conference Call Schedule 2Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 2Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 3Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 4Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 5Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 6Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 7Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 8Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 9Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 10Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 11Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 12
... Vision, Quality of Vision and Contrast ... target illumination and glare luminance levels ... Day/Night testing with/without glare and background ... all ANSI standards. All Light Levels ...
Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Distance Test S.W.C.T. 201: Size 27in x 37 in (68.58cm x 93.98cm),Can be Wal...
Vectograms are the standard for vision training. They are available in fixed or variable,styles to accommodate unlimited base-in and base-out training. Each vectogram,includes one pair,of standard 3-...
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Medicine Products: